Sijun Yang

机构：Hubei Polytechnic University, Huangshi Central Hospital · ORCID：0000-0003-4358-4002

发表论文 37 篇 · 总被引 1151 次 · h-index 17

代表论文

• Inhibition of Miro1 disturbs mitophagy and pancreatic β-cell function interfering insulin release via IRS-Akt-Foxo1 in diabetes (2017 · Oncotarget · 被引 49)
• Celastrol prevents cadmium‐induced neuronal cell death by blocking reactive oxygen species‐mediated mammalian target of rapamycin pathway (2016 · British Journal of Pharmacology · 被引 49)
• Inflammatory signaling pathways in pancreatic β-cell: New insights into type 2 diabetes pathogenesis (2025 · Pharmacological Research · 被引 46)
• Mitochondrial Quality Control in Cardiomyocytes: A Critical Role in the Progression of Cardiovascular Diseases (2020 · Frontiers in Physiology · 被引 46)
• Combination therapy of gefitinib and miR-30a-5p may overcome acquired drug resistance through regulating the PI3K/AKT pathway in non-small cell lung cancer (2020 · Therapeutic Advances in Respiratory Disease · 被引 37)
• MNK as a potential pharmacological target for suppressing LPS-induced acute lung injury in mice (2021 · Biochemical Pharmacology · 被引 25)